Download Files:
Ulodesine
SKU
HY-19480-10 mg
Category Reference compound
Tags Endogenous Metabolite, Metabolic Disease, Metabolic Enzyme/Protease
$420 – $3,490
Products Details
Product Description
– Ulodesine is a purine nucleoside phosphorylase (PNP) inhibitor. Ulodesine inhibits PNP with IC50 value of 2.293 nM/L. Ulodesine can be used for the research of hyporucicemia[1][2].
Web ID
– HY-19480
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C12H16N4O3
References
– [1]Xujuan YANG, et al. Establishment of a novel hyperuricemiaanimal model using mice and assessment ofhyporuricemia action of PNP inhibitor Ulodesine. |[2]Cesar Diaz-Torné, et al. New medications in development for the treatment of hyperuricemia of gout. Curr Opin Rheumatol. 2015 Mar;27(2):164-9.
CAS Number
– 548486-59-5
Molecular Weight
– 264.28
Compound Purity
– 99.00
SMILES
– O=C1C(NC=C2CN3C[C@H](O)[C@@H](CO)C3)=C2NC=N1
Clinical Information
– Phase 2
Research Area
– Metabolic Disease
Solubility
– DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Endogenous Metabolite
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.